0 items USD 0.00Search
Your search for "globaldata relapsed multiple myeloma global clinical trials review h1 2018" gave back 48391 results.
This report evaluates G-protein–coupled receptor family C group 5 member D (GPRC5D) from an industry perspective for its suitability as a tumor-...
Catalog:
La Merie Publishing
July 2022
Price: USD 670.00
CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual...
Catalog:
LPI
March 2023
Price: USD 3,660.00
This report bundle includes four reports about novel cancer targets which have in common a compelling target expression profile with a low risk of on...
Catalog:
La Merie Publishing
July 2022
Price: USD 2,000.00
CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
The global CAR T-Cell Therapy for Multiple Myeloma market size was valued at US$ 160.4 million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
February 2024
Price: USD 3,660.00
CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The “TCR-T Therapy Industry Forecast” looks at past sales and reviews total world TCR-T Therapy sales in 2022, providing a comprehensive analysis by...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Highlights The global TCR-T Therapy market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of %...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Velcade can be used in combination with mefalun and prednisone (MP) in previously untreated patients with multiple myeloma who are not suitable for...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Refractory Multiple Myeloma market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with...
Catalog:
GIR
August 2023
Price: USD 3,480.00
The “Relapsing-Remitting Multiple Sclerosis Industry Forecast” looks at past sales and reviews total world Relapsing-Remitting Multiple Sclerosis...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Multiple myeloma is a cancer formed due to malignant plasma cells. Normal plasma cells are found in the bone marrow and are an important part of the...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The “Proteasome Inhibitors for Multiple Myeloma Industry Forecast” looks at past sales and reviews total world Proteasome Inhibitors for Multiple...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Multiple Myeloma (MM) is a haematological malignancy considered by the propagation of plasma cells in the bone marrow. The disease is incurable;...
Catalog:
LPI
March 2023
Price: USD 3,660.00
